Myomo Reports 2019 Fourth Quarter and Full Year Financial Results Featuring Record Revenue and Gross Margins
Direct Billing Represents 50% of Fourth Quarter Revenue CAMBRIDGE, Mass. (March 12, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the fourth quarter and year ended December 31, 2019. […]
Myomo to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020
Management to host Financial Results Conference Call at 4:15 p.m. ET CAMBRIDGE, Mass. (March 5, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the […]
MYOMO ANNOUNCES CLOSING OF PUBLIC OFFERING
CAMBRIDGE, MA., February 19, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”) a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the closing of its previously announced underwritten public offering of 2,143,000 shares of common stock or common stock equivalents […]
Myomo® Signs Nationwide Payer Network Agreement with HOMELINK
Enables Myomo to Bill “In-network” with 1200 Payers CAMBRIDGE, Mass., February 19, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with HOMELINK which will enable […]
MYOMO ANNOUNCES PRICING OF PUBLIC OFFERING
CAMBRIDGE, Mass., February 11, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”) a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of an underwritten public offering of 2,143,000 shares of common stock or common stock equivalents (which includes […]
Myomo Reports Preliminary Fourth Quarter and Full Year 2019 Results
CAMBRIDGE, MA., February 6, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced preliminary financial and operational results for the fourth quarter and fiscal year ended December 31, 2019. Read more.
Myomo Not Aware of Any Developments to Account for Stock Volatility
CAMBRIDGE, Mass., February 5, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it is unaware of any developments concerning the business of the Company that could account for the recent […]
MyoPro Approved for Reimbursement by German Statutory Health Insurance
Approval To Be Determined on Case-by-Case Basis CAMBRIDGE, Mass., February 3, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Statutory Health Insurance in Germany has approved MyoPro for patients on […]
Myomo Announces One-for-Thirty Reverse Stock Split of its Common Stock
CAMBRIDGE, M.A. January 30, 2020 — Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced following approval of a reverse stock split range and authorized share reduction by stockholders at a special meeting of stockholders earlier today, […]
Myomo Announces Partnership with Hobbs Rehabilitation for UK To Provide Specialist Neurological Rehabilitation Services
CAMBRIDGE, Mass., December 16, 2019 – Myomo®, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has formed a partnership with Hobbs Rehabilitation to provide a range of services to support MyoPro® users […]